Karen M. Anderson insider trades

Open-market stock purchases and sales by Karen M. Anderson, Chief People Officer at Centessa Pharmaceuticals plc, from SEC Form 4 filings since Feb 1, 2019.

Recent trades

DateStockTradeValue
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)—
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$301K
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$109K
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$672K
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$2M
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$2.9M
Mar 26, 2026CNTA Centessa Pharmaceuticals plcSold$1.2M
Mar 26, 2026CNTA Centessa Pharmaceuticals plcBought (not open market)—
Mar 17, 2026CNTA Centessa Pharmaceuticals plcBought (not open market)—
Mar 17, 2026CNTA Centessa Pharmaceuticals plcSold$282K
Mar 16, 2026CNTA Centessa Pharmaceuticals plcBought (not open market)—
Mar 16, 2026CNTA Centessa Pharmaceuticals plcSold$1.8M
Mar 13, 2026CNTA Centessa Pharmaceuticals plcSold$2.8M
Mar 13, 2026CNTA Centessa Pharmaceuticals plcSold$327K
Mar 13, 2026CNTA Centessa Pharmaceuticals plcBought (not open market)—
Mar 13, 2026CNTA Centessa Pharmaceuticals plcBought (not open market)—
Mar 13, 2026CNTA Centessa Pharmaceuticals plcSold$2.8M
Mar 13, 2026CNTA Centessa Pharmaceuticals plcSold$327K
Mar 13, 2026CNTA Centessa Pharmaceuticals plcBought (not open market)—
Feb 2, 2026CNTA Centessa Pharmaceuticals plcBought (not open market)—
Feb 2, 2026CNTA Centessa Pharmaceuticals plcBought (not open market)—
Feb 1, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$261K

Companies traded

  • CNTA Centessa Pharmaceuticals plc: 14 sales, last Jun 24, 2026
  • MIME Mimecast Ltd: 15 sales, last May 19, 2022

Get free alerts when Karen M. Anderson files a new trade →